Literature DB >> 29144814

SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.

Devna Mangrola, Christine Cox, Arianne S Furman, Sridevi Krishnan, Sidika E Karakas.   

Abstract

OBJECTIVE: When glucose records from self blood glucose monitoring (SBGM) do not reflect estimated average glucose from glycosylated hemoglobin (HgBA1) or when patients' clinical symptoms are not explained by their SBGM records, clinical management of diabetes becomes a challenge. Our objective was to determine the magnitude of differences in glucose values reported by SBGM versus those documented by continuous glucose monitoring (CGM).
METHODS: The CGM was conducted by a clinical diabetes educator (CDE)/registered nurse by the clinic protocol, using the Medtronic iPRO2™ system. Patients continued SBGM and managed their diabetes without any change. Data from 4 full days were obtained, and relevant clinical information was recorded. De-identified data sets were provided to the investigators.
RESULTS: Data from 61 patients, 27 with type 1 diabetes (T1DM) and 34 with T2DM were analyzed. The lowest, highest, and average glucose recorded by SBGM were compared to the corresponding values from CGM. The lowest glucose values reported by SBGM were approximately 25 mg/dL higher in both T1DM ( P = .0232) and T2DM ( P = .0003). The highest glucose values by SBGM were approximately 30 mg/dL lower in T1DM ( P = .0005) and 55 mg/dL lower in T2DM ( P<.0001). HgBA1c correlated with the highest and average glucose by SBGM and CGM. The lowest glucose values were seen most frequently during sleep and before breakfast; the highest were seen during the evening and postprandially.
CONCLUSION: SBGM accurately estimates the average glucose but underestimates glucose excursions. CGM uncovers glucose patterns that common SBGM patterns cannot. ABBREVIATIONS: CDE = certified diabetes educator; CGM = continuous glucose monitoring; HgBA1c = glycosylated hemoglobin; MAD = mean absolute difference; SBGM = self blood glucose monitoring; T1DM = type 1 diabetes; T2DM = type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29144814     DOI: 10.4158/EP-2017-0032

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  5 in total

1.  Role of continuous glucose monitoring in the management of glycogen storage disorders.

Authors:  Mrudu Herbert; Surekha Pendyal; Mugdha Rairikar; Carine Halaby; Robert W Benjamin; Priya S Kishnani
Journal:  J Inherit Metab Dis       Date:  2018-05-25       Impact factor: 4.982

2.  Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-analysis.

Authors:  Rajesh Naidu Janapala; Joseph S Jayaraj; Nida Fathima; Tooba Kashif; Norina Usman; Amulya Dasari; Nusrat Jahan; Issac Sachmechi
Journal:  Cureus       Date:  2019-09-12

3.  Assessment of postprandial hyperglycemia and circadian fluctuation of glucose concentrations in diabetic dogs using a flash glucose monitoring system.

Authors:  Emily K Shea; Rebecka S Hess
Journal:  J Vet Intern Med       Date:  2021-02-01       Impact factor: 3.333

4.  Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis.

Authors:  Raffaella Buzzetti; Riccardo C Bonadonna; Andrea Giaccari; Gianluca Perseghin; Domenico Cucinotta; Carmine Fanelli; Angelo Avogaro; Gianluca Aimaretti; Monica Larosa; Ilaria Pacchetti; Geremia B Bolli
Journal:  Diabetes Obes Metab       Date:  2021-10-22       Impact factor: 6.408

Review 5.  Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen.

Authors:  Simon R Heller; Mark Peyrot; Shannon K Oates; April D Taylor
Journal:  BMJ Open Diabetes Res Care       Date:  2020-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.